96 related articles for article (PubMed ID: 20703079)
1. PML promotes senescence via JAK/STAT signaling.
Krämer A
Cell Cycle; 2010 Aug; 9(15):2931. PubMed ID: 20703079
[No Abstract] [Full Text] [Related]
2. Regulation of the PML tumor suppressor in drug-induced senescence of human normal and cancer cells by JAK/STAT-mediated signaling.
Hubackova S; Novakova Z; Krejcikova K; Kosar M; Dobrovolna J; Duskova P; Hanzlikova H; Vancurova M; Barath P; Bartek J; Hodny Z
Cell Cycle; 2010 Aug; 9(15):3085-99. PubMed ID: 20699642
[TBL] [Abstract][Full Text] [Related]
3. The helicase HAGE prevents interferon-α-induced PML expression in ABCB5+ malignant melanoma-initiating cells by promoting the expression of SOCS1.
Mathieu MG; Miles AK; Ahmad M; Buczek ME; Pockley AG; Rees RC; Regad T
Cell Death Dis; 2014 Feb; 5(2):e1061. PubMed ID: 24525737
[TBL] [Abstract][Full Text] [Related]
4. Interleukin 6 signaling regulates promyelocytic leukemia protein gene expression in human normal and cancer cells.
Hubackova S; Krejcikova K; Bartek J; Hodny Z
J Biol Chem; 2012 Aug; 287(32):26702-14. PubMed ID: 22711534
[TBL] [Abstract][Full Text] [Related]
5. PML/RARα-Regulated miR-181a/b Cluster Targets the Tumor Suppressor RASSF1A in Acute Promyelocytic Leukemia.
Bräuer-Hartmann D; Hartmann JU; Wurm AA; Gerloff D; Katzerke C; Verga Falzacappa MV; Pelicci PG; Müller-Tidow C; Tenen DG; Niederwieser D; Behre G
Cancer Res; 2015 Aug; 75(16):3411-24. PubMed ID: 26041820
[TBL] [Abstract][Full Text] [Related]
6. PML links aberrant cytokine signaling and oncogenic stress to cellular senescence.
Bourdeau V; Baudry D; Ferbeyre G
Front Biosci (Landmark Ed); 2009 Jan; 14(2):475-85. PubMed ID: 19273079
[TBL] [Abstract][Full Text] [Related]
7. Restoring PML tumor suppression to combat cancer.
Wolyniec K; Chan AL; Haupt S; Haupt Y
Cell Cycle; 2012 Oct; 11(20):3705-6. PubMed ID: 22983003
[No Abstract] [Full Text] [Related]
8. Novel therapies for myelofibrosis.
Stein BL; Cervantes F; Giles F; Harrison CN; Verstovsek S
Leuk Lymphoma; 2015; 56(10):2768-78. PubMed ID: 25860240
[TBL] [Abstract][Full Text] [Related]
9. Physical and functional interaction between PML and TBX2 in the establishment of cellular senescence.
Martin N; Benhamed M; Nacerddine K; Demarque MD; van Lohuizen M; Dejean A; Bischof O
EMBO J; 2012 Jan; 31(1):95-109. PubMed ID: 22002537
[TBL] [Abstract][Full Text] [Related]
10. Promyelocytic Leukemia Protein Isoform II Promotes Transcription Factor Recruitment To Activate Interferon Beta and Interferon-Responsive Gene Expression.
Chen Y; Wright J; Meng X; Leppard KN
Mol Cell Biol; 2015 May; 35(10):1660-72. PubMed ID: 25733689
[TBL] [Abstract][Full Text] [Related]
11. CK2 and PML: regulating the regulator.
Lallemand-Breitenbach V; de Thé H
Cell; 2006 Jul; 126(2):244-5. PubMed ID: 16873055
[TBL] [Abstract][Full Text] [Related]
12. [Structure and functions of isoforms of polyfunctional tumoral suppressor PML].
Zinov'eva MV; Vaĭshlia NA; Vinogradova TV; Kopantsev EP; Sverdlov ED
Mol Gen Mikrobiol Virusol; 2009; (2):15-21. PubMed ID: 19517805
[TBL] [Abstract][Full Text] [Related]
13. PML: a tumor suppressor that regulates cell fate in mammary gland.
Li W; Rich T; Watson CJ
Cell Cycle; 2009 Sep; 8(17):2711-7. PubMed ID: 19652541
[TBL] [Abstract][Full Text] [Related]
14. Arsenic trioxide disrupts glioma stem cells via promoting PML degradation to inhibit tumor growth.
Zhou W; Cheng L; Shi Y; Ke SQ; Huang Z; Fang X; Chu CW; Xie Q; Bian XW; Rich JN; Bao S
Oncotarget; 2015 Nov; 6(35):37300-15. PubMed ID: 26510911
[TBL] [Abstract][Full Text] [Related]
15. PML mediates glioblastoma resistance to mammalian target of rapamycin (mTOR)-targeted therapies.
Iwanami A; Gini B; Zanca C; Matsutani T; Assuncao A; Nael A; Dang J; Yang H; Zhu S; Kohyama J; Kitabayashi I; Cavenee WK; Cloughesy TF; Furnari FB; Nakamura M; Toyama Y; Okano H; Mischel PS
Proc Natl Acad Sci U S A; 2013 Mar; 110(11):4339-44. PubMed ID: 23440206
[TBL] [Abstract][Full Text] [Related]
16. The reduced and altered activities of PAX5 are linked to the protein-protein interaction motif (coiled-coil domain) of the PAX5-PML fusion protein in t(9;15)-associated acute lymphocytic leukemia.
Qiu JJ; Chu H; Lu X; Jiang X; Dong S
Oncogene; 2011 Feb; 30(8):967-77. PubMed ID: 20972455
[TBL] [Abstract][Full Text] [Related]
17. PML depletion disrupts normal mammary gland development and skews the composition of the mammary luminal cell progenitor pool.
Li W; Ferguson BJ; Khaled WT; Tevendale M; Stingl J; Poli V; Rich T; Salomoni P; Watson CJ
Proc Natl Acad Sci U S A; 2009 Mar; 106(12):4725-30. PubMed ID: 19261859
[TBL] [Abstract][Full Text] [Related]
18. Promyelocytic leukemia-nuclear body formation is an early event leading to retinoic acid-induced differentiation of neuroblastoma cells.
Delaune A; Corbière C; Benjelloun FD; Legrand E; Vannier JP; Ripoll C; Vasse M
J Neurochem; 2008 Jan; 104(1):89-99. PubMed ID: 17986232
[TBL] [Abstract][Full Text] [Related]
19. Tyrosine kinase inhibitor, methyl 2,5-dihydromethylcinnimate, induces PML nuclear body formation and apoptosis in tumor cells.
Komura N; Asakawa M; Umezawa K; Segawa K
Exp Cell Res; 2007 Aug; 313(13):2753-65. PubMed ID: 17585903
[TBL] [Abstract][Full Text] [Related]
20. Regulation of E2Fs and senescence by PML nuclear bodies.
Vernier M; Bourdeau V; Gaumont-Leclerc MF; Moiseeva O; Bégin V; Saad F; Mes-Masson AM; Ferbeyre G
Genes Dev; 2011 Jan; 25(1):41-50. PubMed ID: 21205865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
